Breaking News - The Fly

Open Search

KZR

Kezar Life Sciences

$

()

Kezar Life Sciences reports Q4 EPS (44c), consensus (38c)

KZR

3/14/2024 - 16:03pm

Everest Medicines, Kezar Life Sciences get China IND approval for PALIZADE trial

KZR

2/26/2024 - 18:13pm

Kezar Life Sciences reports Q3 EPS (32c), consensus (35c)

KZR

11/13/2023 - 16:03pm

Kezar Life Sciences downgraded to Hold from Buy at JonesResearch

KZR

10/4/2023 - 16:31pm

Fly Intel: After-Hours Movers

BROG , OCUL , ORC

…

10/3/2023 - 18:42pm

Kezar Life Sciences trading resumes

KZR

10/3/2023 - 16:40pm

Kezar Life Sciences to resume trading at 4:40 pm ET

KZR

10/3/2023 - 16:20pm

Kezar Life Sciences CEO John Fowler to step down

KZR

10/3/2023 - 16:12pm

Kezar Life Sciences announces strategic restructuring, 41% workforce reduction

KZR

10/3/2023 - 16:11pm

Kezar Life Sciences trading halted, news pending

KZR

10/3/2023 - 16:05pm

Kezar Life Sciences price target raised to $20 from $18 at H.C. Wainwright

KZR

9/25/2023 - 06:17am

Kezar Life Sciences enters into collaboration pact with Everest Medicines

KZR

9/20/2023 - 18:31pm

Kezar Life Sciences downgraded to Equal Weight from Overweight at Wells Fargo

KZR

8/11/2023 - 07:11am

Kezar Life Sciences price target lowered to $18 from $19 at H.C. Wainwright

KZR

8/11/2023 - 06:27am

Kezar Life Sciences reports Q2 EPS (34c), consensus (32c)

KZR

8/10/2023 - 16:05pm